{
    "2020-03-04": [
        [
            {
                "time": "",
                "original_text": "富时罗素宣布对富时中国A50指数等多个指数季度审核变更",
                "features": {
                    "keywords": [
                        "富时罗素",
                        "富时中国A50指数",
                        "季度审核",
                        "变更"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "指数基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "盘点巨头医药投资布局：BAT重AI，药明康德等重技术",
                "features": {
                    "keywords": [
                        "医药",
                        "BAT",
                        "AI",
                        "药明康德",
                        "技术"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "在带量采购冲击下，国产创新药及CRO企业更受关注",
                "features": {
                    "keywords": [
                        "带量采购",
                        "国产创新药",
                        "CRO企业",
                        "关注"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德升近4% 创上市新高",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股价上涨",
                        "上市新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}